SILO PHARMA, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
SILO PHARMA, INC. (SILO) had Stock Issued During Period, Value, Restricted Stock Award, Gross of $135.10 thousand as of 2022-08-29, per its 10-K filed 2025-03-28.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2025-03-28
- 2022-08-29: Stock Issued During Period, Value, Restricted Stock Award, Gross $135.10K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross |
|---|---|
| 2022-08-29 | $135.10K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |